Butamirate is an antitussive agent used for the symptomatic treatment of dry cough. It is not related to opioids such as codeine. Its effects are based on a central mechanism of action. Non-sustained-release dosage forms are usually administered three to four times daily before meals. Possible adverse effects include dizziness, drowsiness, nausea, diarrhoea, and skin rash.
Butamirate (ATC R05DB13) is attributed with antitussive and bronchospasmolytic properties. Its effects are based on a central mechanism of action.
PillsCard reference image